Nanthealth Stock Buy Hold or Sell Recommendation

NH -  USA Stock  

USD 0.48  0.06  11.11%

Allowing for the 90-day total investment horizon and your above-average risk tolerance, our recommendation regarding Nanthealth is 'Strong Sell'. Macroaxis provides Nanthealth buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding NH positions. The advice algorithm takes into account all of Nanthealth's available fundamental, technical, and predictive indicators you will find on this site.
  
Refresh
The advice is provided from Nanthealth's buy-and-hold perspective. Additionally, see Nanthealth Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. We conduct extensive research on individual companies such as Nanthealth and provide practical buy, sell, or hold advice based on selected investing horizon and risk tolerance towards Nanthealth.

Execute Nanthealth Buy or Sell Advice

The Nanthealth recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Nanthealth. Macroaxis does not own or have any residual interests in Nanthealth or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Nanthealth's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell NanthealthBuy Nanthealth
Strong Sell

Volatility

Extremely DangerousDetails

Hype Condition

Under hypedDetails

Current Valuation

UndervaluedDetails

Odds of Distress

Very HighDetails

Economic Sensitivity

Follows the market closelyDetails

Analyst Consensus

Strong BuyDetails

Financial Strenth (F Score)

FrailDetails

Financial Leverage

InapplicableDetails

Reporting Quality (M-Score)

Possible ManipulatorDetails
For the selected time horizon Nanthealth has a Mean Deviation of 3.74, Standard Deviation of 5.19 and Variance of 26.96
We provide investment recommendation to complement the last-minute expert consensus on Nanthealth. Our dynamic recommendation engine harnesses a multidimensional algorithm to analyze the entity's potential to grow using all technical and fundamental data available at the time. To make sure Nanthealth is not overpriced, please verify all Nanthealth fundamentals, including its price to sales, book value per share, current asset, as well as the relationship between the cash and equivalents and beta . As Nanthealth appears to be a penny stock we also strongly suggest to check its number of shares shorted numbers.

Nanthealth Trading Alerts and Improvement Suggestions

Nanthealth generated a negative expected return over the last 90 days
Nanthealth has high historical volatility and very poor performance
Nanthealth has some characteristics of a very speculative penny stock
Nanthealth has a very high chance of going through financial distress in the upcoming years
The company generated the yearly revenue of 62.65 M. Annual Net Loss to common stockholders was (58.28 M) with gross profit of 39.83 M.
Nanthealth reports about 29.08 M in cash with (27.69 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.25.
Nanthealth has a frail financial position based on the latest SEC disclosures
Roughly 58.0% of the company outstanding shares are owned by corporate insiders
Latest headline from www.designerwomen.co.uk: Precision Medicine Software Market Investment Analysis Designer Women - Designer Women

Nanthealth current analysts advice

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Nanthealth analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Nanthealth analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Mean Price3.25
Target Median Price3.25
Target High Price4.00
Number Of Analyst Opinions2
Target Low Price2.50
Average Consensus Strong Buy
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.

Nanthealth Returns Distribution Density

The distribution of Nanthealth's historical returns is an attempt to chart the future uncertainty of Nanthealth's future price movements. The chart of the probability distribution of Nanthealth stock daily returns describes the distribution of returns around its average expected value. We use Nanthealth price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Nanthealth returns is essential to provide solid investment advice for Nanthealth stock.
Mean Return-0.62Value At Risk-8.93
Potential Upside9.43Standard Deviation5.19
 Return Density 
      Distribution 
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Nanthealth historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Nanthealth Cash Flow Accounts

201720182019202020212022 (projected)
Capital Expenditure(13.64 M)(10.55 M)(4.59 M)(5.67 M)(6.52 M)(7.04 M)
Depreciation Amortization and Accretion28.05 M22.36 M22.36 M16.77 M19.29 M22.76 M
Net Cash Flow or Change in Cash and Cash Equivalents(98.69 M)(42.57 M)(13.06 M)17.78 M16 M17.27 M
Net Cash Flow Business Acquisitions and Disposals1.72 M68 K300 K40.93 M47.06 M50.78 M
Net Cash Flow from Financing171.69 M313.59 M(5.33 M)(2.16 M)(2.48 M)(2.55 M)
Net Cash Flow from Investing(93.51 M)(88.77 M)(12.28 M)(10.48 M)(9.43 M)(10.17 M)
Net Cash Flow from Operations(75.75 M)(70.63 M)(81.15 M)(29.63 M)(26.67 M)(28.77 M)
Effect of Exchange Rate Changes on Cash65 K(300 K)25 K(62 K)(55.8 K)(57.27 K)
Share Based Compensation4.51 M5.66 M2.79 M2.65 M2.38 M2.45 M

Nanthealth Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Nanthealth or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Nanthealth stock's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Nanthealth stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over DOW
-0.54
β
Beta against DOW0.57
σ
Overall volatility
5.36
Ir
Information ratio -0.09

Nanthealth Volatility Alert

Nanthealth exhibits very low volatility with skewness of -0.08 and kurtosis of 1.01. However, we advise investors to further study Nanthealth technical indicators to make sure all market info is available and is reliable. Nanthealth is a potential penny stock. Although Nanthealth may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Nanthealth. We encourage investors to look for the signals such us email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Nanthealth instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of an artificial hype usually unable to maintain its increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.

Nanthealth Fundamentals Vs Peers

Comparing Nanthealth's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Nanthealth's direct or indirect competition across all of the common fundamentals between Nanthealth and the related equities. This way, we can detect undervalued stocks with similar characteristics as Nanthealth or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Nanthealth's fundamental indicators could also be used in its relative valuation, which is a method of valuing Nanthealth by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Nanthealth to competition
FundamentalsNanthealthPeer Average
Return On Equity1.80 %(0.31) %
Return On Asset(12.84) %(0.14) %
Profit Margin(92.99) %(1.27) %
Operating Margin(65.28) %(5.51) %
Current Valuation310.77 M16.62 B
Shares Outstanding115.44 M571.82 M
Shares Owned by Insiders58.45 %10.09 %
Shares Owned by Institutions20.74 %39.21 %
Number of Shares Shorted973.85 K4.71 M
Price to Earning(2.25) X28.72 X
Price to Book27.11 X9.51 X
Price to Sales0.94 X11.42 X
Revenue62.65 M9.43 B
Gross Profit39.83 M27.38 B
EBITDA(35.05 M)3.9 B
Net Income(58.28 M)570.98 M
Cash and Equivalents29.08 M2.7 B
Cash per Share0.25 X5.01 X
Total Debt258.48 M5.32 B
Debt to Equity44.90 %48.70 %
Current Ratio1.41 X2.16 X
Book Value Per Share(1.27) X1.93 K
Cash Flow from Operations(27.69 M)971.22 M
Short Ratio10.81 X4.00 X
Earnings Per Share(0.55) X3.12 X
Number of Employees32618.84 K
Beta1.76-0.15
Market Capitalization58.9 M19.03 B
Total Asset411.95 M29.47 B
Retained Earnings(971.8 M)9.33 B
Working Capital(10.21 M)1.48 B
Current Asset33.03 M9.34 B
Current Liabilities43.24 M7.9 B
   Acquisition by Wise Deanna L of 100000 shares of Nanthealth subject to Rule 16b-3 [view details]

Nanthealth Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Nanthealth . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
Accumulation Distribution517700.0
Daily Balance Of Power(0.50)
Rate Of Daily Change0.89
Day Median Price0.54
Day Typical Price0.52
Price Action Indicator(0.09)

About Nanthealth Buy or Sell Advice

When is the right time to buy or sell Nanthealth? Buying financial instruments such as Nanthealth Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the stock market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Although Nanthealth investors may find it confusing at the beginning, most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
 2017 2018 2021 2022 (projected)
Receivables11.49 M15.29 M13.76 M12.03 M
Inventories839 K496 K570.4 K585.41 K

Use Investing Ideas to Build Portfolios

In addition to having Nanthealth in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Banks Thematic Idea Now

Banks
Banks Theme
Large and small money and credit banks and credit services. The Banks theme has 30 constituents.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Banks Theme or any other thematic opportunities.
View All  Next Launch Banks
Additionally, see Nanthealth Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note that the Nanthealth information on this page should be used as a complementary analysis to other Nanthealth's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Focused Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Complementary Tools for Nanthealth Stock analysis

When running Nanthealth price analysis, check to measure Nanthealth's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nanthealth is operating at the current time. Most of Nanthealth's value examination focuses on studying past and present price action to predict the probability of Nanthealth's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Nanthealth's price. Additionally, you may evaluate how the addition of Nanthealth to your portfolios can decrease your overall portfolio volatility.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Is Nanthealth's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nanthealth. If investors know Nanthealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nanthealth listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
64.7 M
Quarterly Revenue Growth YOY
0.013
Return On Assets
-0.15
The market value of Nanthealth is measured differently than its book value, which is the value of Nanthealth that is recorded on the company's balance sheet. Investors also form their own opinion of Nanthealth's value that differs from its market value or its book value, called intrinsic value, which is Nanthealth's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nanthealth's market value can be influenced by many factors that don't directly affect Nanthealth's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nanthealth's value and its price as these two are different measures arrived at by different means. Investors typically determine Nanthealth value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nanthealth's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.